TSP49122-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to nesbuvir


TSA214842-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir


TSA214884-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir


TSA214931-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir


TSA214984-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir


TSA215037-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir


TSA215084-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir


TSA215136-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir


TSA215187-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir


TSA215215-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir


TSA215268-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir


TSA215305-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to nesbuvir


TSA215354-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir


TSA215406-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir


TSF512835-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir 0.125 µM for 24.0 h


1 subfactor(s)
TSF512831-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir 10.0 µM for 24.0 h


1 subfactor(s)
TSF512836-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir 0.04 µM for 24.0 h


1 subfactor(s)
TSF512832-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir 3.33 µM for 24.0 h


1 subfactor(s)
TSF512833-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir 1.11 µM for 24.0 h


1 subfactor(s)
TSF512834-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir 0.37 µM for 24.0 h


1 subfactor(s)
TSF620737-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir 0.25 µM for 24.0 h


1 subfactor(s)
TSF620735-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir 2.22 µM for 24.0 h


1 subfactor(s)
TSF620739-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir 0.03 µM for 24.0 h


1 subfactor(s)
TSF620736-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir 0.74 µM for 24.0 h


1 subfactor(s)
TSF620738-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir 0.08 µM for 24.0 h


1 subfactor(s)
TSF620740-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir 0.01 µM for 24.0 h


1 subfactor(s)
TSF513117-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir 0.37 µM for 24.0 h


1 subfactor(s)
TSF513118-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir 0.125 µM for 24.0 h


1 subfactor(s)
TSF513114-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir 10.0 µM for 24.0 h


1 subfactor(s)
TSF513115-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir 3.33 µM for 24.0 h


1 subfactor(s)
TSF513116-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir 1.11 µM for 24.0 h


1 subfactor(s)
TSF513119-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir 0.04 µM for 24.0 h


1 subfactor(s)
TSF621060-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir 2.22 µM for 24.0 h


1 subfactor(s)
TSF621061-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir 0.74 µM for 24.0 h


1 subfactor(s)
TSF621062-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir 0.25 µM for 24.0 h


1 subfactor(s)
TSF621063-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir 0.08 µM for 24.0 h


1 subfactor(s)
TSF621064-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir 0.03 µM for 24.0 h


1 subfactor(s)
TSF621065-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir 0.01 µM for 24.0 h


1 subfactor(s)
TSF513405-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir 10.0 µM for 24.0 h


1 subfactor(s)
TSF513406-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir 3.33 µM for 24.0 h


1 subfactor(s)
TSF513407-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir 1.11 µM for 24.0 h


1 subfactor(s)
TSF513408-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir 0.37 µM for 24.0 h


1 subfactor(s)
TSF513409-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir 0.125 µM for 24.0 h


1 subfactor(s)
TSF513410-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir 0.04 µM for 24.0 h


1 subfactor(s)
TSF621393-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir 2.22 µM for 24.0 h


1 subfactor(s)
TSF621394-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir 0.74 µM for 24.0 h


1 subfactor(s)
TSF621395-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir 0.25 µM for 24.0 h


1 subfactor(s)
TSF621396-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir 0.08 µM for 24.0 h


1 subfactor(s)
TSF621397-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir 0.03 µM for 24.0 h


1 subfactor(s)
TSF621398-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir 0.01 µM for 24.0 h


1 subfactor(s)
TSF513709-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir 10.0 µM for 24.0 h


1 subfactor(s)
TSF513710-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir 3.33 µM for 24.0 h


1 subfactor(s)
TSF513711-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir 1.11 µM for 24.0 h


1 subfactor(s)
TSF513712-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir 0.37 µM for 24.0 h


1 subfactor(s)
TSF513713-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir 0.125 µM for 24.0 h


1 subfactor(s)
TSF513714-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir 0.04 µM for 24.0 h


1 subfactor(s)
TSF621719-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir 2.22 µM for 24.0 h


1 subfactor(s)
TSF621720-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir 0.74 µM for 24.0 h


1 subfactor(s)
TSF621723-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir 0.03 µM for 24.0 h


1 subfactor(s)
TSF621721-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir 0.25 µM for 24.0 h


1 subfactor(s)
TSF621722-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir 0.08 µM for 24.0 h


1 subfactor(s)
TSF621724-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir 0.01 µM for 24.0 h


1 subfactor(s)
TSF514030-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir 3.33 µM for 24.0 h


1 subfactor(s)
TSF514029-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir 10.0 µM for 24.0 h


1 subfactor(s)
TSF514031-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir 1.11 µM for 24.0 h


1 subfactor(s)
TSF514032-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir 0.37 µM for 24.0 h


1 subfactor(s)
TSF514033-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir 0.125 µM for 24.0 h


1 subfactor(s)
TSF514034-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir 0.04 µM for 24.0 h


1 subfactor(s)
TSF622053-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir 2.22 µM for 24.0 h


1 subfactor(s)
TSF622054-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir 0.74 µM for 24.0 h


1 subfactor(s)
TSF622055-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir 0.25 µM for 24.0 h


1 subfactor(s)
TSF622056-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir 0.08 µM for 24.0 h


1 subfactor(s)
TSF622057-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir 0.03 µM for 24.0 h


1 subfactor(s)
TSF622058-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir 0.01 µM for 24.0 h


1 subfactor(s)
TSF514327-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir 1.11 µM for 24.0 h


1 subfactor(s)
TSF514325-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir 10.0 µM for 24.0 h


1 subfactor(s)
TSF514326-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir 3.33 µM for 24.0 h


1 subfactor(s)
TSF514328-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir 0.37 µM for 24.0 h


1 subfactor(s)
TSF514329-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir 0.125 µM for 24.0 h


1 subfactor(s)
TSF514330-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir 0.04 µM for 24.0 h


1 subfactor(s)
TSF622389-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir 2.22 µM for 24.0 h


1 subfactor(s)
TSF622390-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir 0.74 µM for 24.0 h


1 subfactor(s)
TSF622394-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir 0.01 µM for 24.0 h


1 subfactor(s)
TSF622391-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir 0.25 µM for 24.0 h


1 subfactor(s)
TSF622392-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir 0.08 µM for 24.0 h


1 subfactor(s)
TSF622393-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir 0.03 µM for 24.0 h


1 subfactor(s)
TSF514638-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir 10.0 µM for 24.0 h


1 subfactor(s)
TSF514642-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir 0.125 µM for 24.0 h


1 subfactor(s)
TSF514639-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir 3.33 µM for 24.0 h


1 subfactor(s)
TSF514640-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir 1.11 µM for 24.0 h


1 subfactor(s)
TSF514641-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir 0.37 µM for 24.0 h


1 subfactor(s)
TSF514643-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir 0.04 µM for 24.0 h


1 subfactor(s)
TSF622723-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir 0.74 µM for 24.0 h


1 subfactor(s)
TSF622722-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir 2.22 µM for 24.0 h


1 subfactor(s)
TSF622724-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir 0.25 µM for 24.0 h


1 subfactor(s)
TSF622725-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir 0.08 µM for 24.0 h


1 subfactor(s)
TSF622726-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir 0.03 µM for 24.0 h


1 subfactor(s)
TSF622727-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir 0.01 µM for 24.0 h


1 subfactor(s)
TSF514961-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir 0.37 µM for 24.0 h


1 subfactor(s)
TSF514958-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir 10.0 µM for 24.0 h


1 subfactor(s)
TSF514962-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir 0.125 µM for 24.0 h


1 subfactor(s)
TSF514959-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir 3.33 µM for 24.0 h


1 subfactor(s)
TSF514960-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir 1.11 µM for 24.0 h


1 subfactor(s)
TSF514963-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir 0.04 µM for 24.0 h


1 subfactor(s)
TSF623057-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir 2.22 µM for 24.0 h


1 subfactor(s)
TSF623058-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir 0.74 µM for 24.0 h


1 subfactor(s)
TSF623061-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir 0.03 µM for 24.0 h


1 subfactor(s)
TSF623059-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir 0.25 µM for 24.0 h


1 subfactor(s)
TSF623060-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir 0.08 µM for 24.0 h


1 subfactor(s)
TSF623062-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir 0.01 µM for 24.0 h


1 subfactor(s)
TSF515236-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir 0.37 µM for 24.0 h


1 subfactor(s)
TSF515233-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir 10.0 µM for 24.0 h


1 subfactor(s)
TSF515237-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir 0.125 µM for 24.0 h


1 subfactor(s)
TSF515234-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir 3.33 µM for 24.0 h


1 subfactor(s)
TSF515235-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir 1.11 µM for 24.0 h


1 subfactor(s)
TSF515238-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir 0.04 µM for 24.0 h


1 subfactor(s)
TSF623390-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir 2.22 µM for 24.0 h


1 subfactor(s)
TSF623391-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir 0.74 µM for 24.0 h


1 subfactor(s)
TSF623392-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir 0.25 µM for 24.0 h


1 subfactor(s)
TSF623393-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir 0.08 µM for 24.0 h


1 subfactor(s)
TSF623394-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir 0.03 µM for 24.0 h


1 subfactor(s)
TSF623395-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir 0.01 µM for 24.0 h


1 subfactor(s)
TSF515547-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir 10.0 µM for 24.0 h


1 subfactor(s)
TSF515548-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir 3.33 µM for 24.0 h


1 subfactor(s)
TSF515549-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir 1.11 µM for 24.0 h


1 subfactor(s)
TSF515550-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir 0.37 µM for 24.0 h


1 subfactor(s)
TSF515551-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir 0.125 µM for 24.0 h


1 subfactor(s)
TSF515552-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir 0.04 µM for 24.0 h


1 subfactor(s)
TSF623714-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir 2.22 µM for 24.0 h


1 subfactor(s)
TSF623715-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir 0.74 µM for 24.0 h


1 subfactor(s)
TSF623716-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir 0.25 µM for 24.0 h


1 subfactor(s)
TSF623717-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir 0.08 µM for 24.0 h


1 subfactor(s)
TSF623718-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir 0.03 µM for 24.0 h


1 subfactor(s)
TSF623719-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir 0.01 µM for 24.0 h


1 subfactor(s)
TSF515819-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to nesbuvir 3.33 µM for 24.0 h


1 subfactor(s)
TSF515818-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to nesbuvir 10.0 µM for 24.0 h


1 subfactor(s)
TSF515820-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to nesbuvir 1.11 µM for 24.0 h


1 subfactor(s)
TSF515821-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to nesbuvir 0.37 µM for 24.0 h


1 subfactor(s)
TSF515822-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to nesbuvir 0.125 µM for 24.0 h


1 subfactor(s)
TSF515823-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to nesbuvir 0.04 µM for 24.0 h


1 subfactor(s)
TSF516135-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir 10.0 µM for 24.0 h


1 subfactor(s)
TSF516136-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir 3.33 µM for 24.0 h


1 subfactor(s)
TSF516137-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir 1.11 µM for 24.0 h


1 subfactor(s)
TSF516138-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir 0.37 µM for 24.0 h


1 subfactor(s)
TSF516139-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir 0.125 µM for 24.0 h


1 subfactor(s)
TSF516140-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir 0.04 µM for 24.0 h


1 subfactor(s)
TSF624048-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir 2.22 µM for 24.0 h


1 subfactor(s)
TSF624049-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir 0.74 µM for 24.0 h


1 subfactor(s)
TSF624050-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir 0.25 µM for 24.0 h


1 subfactor(s)
TSF624051-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir 0.08 µM for 24.0 h


1 subfactor(s)
TSF624052-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir 0.03 µM for 24.0 h


1 subfactor(s)
TSF624053-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir 0.01 µM for 24.0 h


1 subfactor(s)
TSF516452-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir 10.0 µM for 24.0 h


1 subfactor(s)
TSF516453-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir 3.33 µM for 24.0 h


1 subfactor(s)
TSF516454-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir 1.11 µM for 24.0 h


1 subfactor(s)
TSF516455-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir 0.37 µM for 24.0 h


1 subfactor(s)
TSF516456-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir 0.125 µM for 24.0 h


1 subfactor(s)
TSF516457-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir 0.04 µM for 24.0 h


1 subfactor(s)
TSF624384-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir 0.01 µM for 24.0 h


1 subfactor(s)
TSF624379-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir 2.22 µM for 24.0 h


1 subfactor(s)
TSF624380-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir 0.74 µM for 24.0 h


1 subfactor(s)
TSF624381-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir 0.25 µM for 24.0 h


1 subfactor(s)
TSF624382-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir 0.08 µM for 24.0 h


1 subfactor(s)
TSF624383-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir 0.03 µM for 24.0 h


1 subfactor(s)
TSS512845-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir 0.125 µM for 24.0 h


TSS512841-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir 10.0 µM for 24.0 h


TSS512846-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir 0.04 µM for 24.0 h


TSS512842-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir 3.33 µM for 24.0 h


TSS512843-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir 1.11 µM for 24.0 h


TSS512844-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir 0.37 µM for 24.0 h


TSS620748-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir 0.25 µM for 24.0 h


TSS620746-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir 2.22 µM for 24.0 h


TSS620750-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir 0.03 µM for 24.0 h


TSS620747-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir 0.74 µM for 24.0 h


TSS620749-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir 0.08 µM for 24.0 h


TSS620751-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to nesbuvir 0.01 µM for 24.0 h


TSS513127-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir 0.37 µM for 24.0 h


TSS513128-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir 0.125 µM for 24.0 h


TSS513124-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir 10.0 µM for 24.0 h


TSS513125-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir 3.33 µM for 24.0 h


TSS513126-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir 1.11 µM for 24.0 h


TSS513129-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir 0.04 µM for 24.0 h


TSS621071-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir 2.22 µM for 24.0 h


TSS621072-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir 0.74 µM for 24.0 h


TSS621073-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir 0.25 µM for 24.0 h


TSS621074-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir 0.08 µM for 24.0 h


TSS621075-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir 0.03 µM for 24.0 h


TSS621076-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to nesbuvir 0.01 µM for 24.0 h


TSS513415-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir 10.0 µM for 24.0 h


TSS513416-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir 3.33 µM for 24.0 h


TSS513417-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir 1.11 µM for 24.0 h


TSS513418-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir 0.37 µM for 24.0 h


TSS513419-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir 0.125 µM for 24.0 h


TSS513420-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir 0.04 µM for 24.0 h


TSS621404-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir 2.22 µM for 24.0 h


TSS621405-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir 0.74 µM for 24.0 h


TSS621406-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir 0.25 µM for 24.0 h


TSS621407-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir 0.08 µM for 24.0 h


TSS621408-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir 0.03 µM for 24.0 h


TSS621409-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to nesbuvir 0.01 µM for 24.0 h


TSS513719-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir 10.0 µM for 24.0 h


TSS513720-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir 3.33 µM for 24.0 h


TSS513721-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir 1.11 µM for 24.0 h


TSS513722-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir 0.37 µM for 24.0 h


TSS513723-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir 0.125 µM for 24.0 h


TSS513724-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir 0.04 µM for 24.0 h


TSS621730-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir 2.22 µM for 24.0 h


TSS621731-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir 0.74 µM for 24.0 h


TSS621734-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir 0.03 µM for 24.0 h


TSS621732-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir 0.25 µM for 24.0 h


TSS621733-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir 0.08 µM for 24.0 h


TSS621735-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to nesbuvir 0.01 µM for 24.0 h


TSS514040-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir 3.33 µM for 24.0 h


TSS514039-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir 10.0 µM for 24.0 h


TSS514041-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir 1.11 µM for 24.0 h


TSS514042-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir 0.37 µM for 24.0 h


TSS514043-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir 0.125 µM for 24.0 h


TSS514044-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir 0.04 µM for 24.0 h


TSS622064-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir 2.22 µM for 24.0 h


TSS622065-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir 0.74 µM for 24.0 h


TSS622066-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir 0.25 µM for 24.0 h


TSS622067-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir 0.08 µM for 24.0 h


TSS622068-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir 0.03 µM for 24.0 h


TSS622069-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to nesbuvir 0.01 µM for 24.0 h


TSS514337-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir 1.11 µM for 24.0 h


TSS514335-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir 10.0 µM for 24.0 h


TSS514336-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir 3.33 µM for 24.0 h


TSS514338-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir 0.37 µM for 24.0 h


TSS514339-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir 0.125 µM for 24.0 h


TSS514340-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir 0.04 µM for 24.0 h


TSS622400-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir 2.22 µM for 24.0 h


TSS622401-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir 0.74 µM for 24.0 h


TSS622405-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir 0.01 µM for 24.0 h


TSS622402-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir 0.25 µM for 24.0 h


TSS622403-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir 0.08 µM for 24.0 h


TSS622404-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to nesbuvir 0.03 µM for 24.0 h


TSS514648-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir 10.0 µM for 24.0 h


TSS514652-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir 0.125 µM for 24.0 h


TSS514649-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir 3.33 µM for 24.0 h


TSS514650-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir 1.11 µM for 24.0 h


TSS514651-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir 0.37 µM for 24.0 h


TSS514653-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir 0.04 µM for 24.0 h


TSS622734-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir 0.74 µM for 24.0 h


TSS622733-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir 2.22 µM for 24.0 h


TSS622735-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir 0.25 µM for 24.0 h


TSS622736-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir 0.08 µM for 24.0 h


TSS622737-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir 0.03 µM for 24.0 h


TSS622738-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to nesbuvir 0.01 µM for 24.0 h


TSS514971-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir 0.37 µM for 24.0 h


TSS514968-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir 10.0 µM for 24.0 h


TSS514972-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir 0.125 µM for 24.0 h


TSS514969-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir 3.33 µM for 24.0 h


TSS514970-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir 1.11 µM for 24.0 h


TSS514973-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir 0.04 µM for 24.0 h


TSS623068-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir 2.22 µM for 24.0 h


TSS623069-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir 0.74 µM for 24.0 h


TSS623072-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir 0.03 µM for 24.0 h


TSS623070-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir 0.25 µM for 24.0 h


TSS623071-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir 0.08 µM for 24.0 h


TSS623073-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to nesbuvir 0.01 µM for 24.0 h


TSS515246-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir 0.37 µM for 24.0 h


TSS515243-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir 10.0 µM for 24.0 h


TSS515247-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir 0.125 µM for 24.0 h


TSS515244-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir 3.33 µM for 24.0 h


TSS515245-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir 1.11 µM for 24.0 h


TSS515248-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir 0.04 µM for 24.0 h


TSS623401-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir 2.22 µM for 24.0 h


TSS623402-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir 0.74 µM for 24.0 h


TSS623403-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir 0.25 µM for 24.0 h


TSS623404-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir 0.08 µM for 24.0 h


TSS623405-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir 0.03 µM for 24.0 h


TSS623406-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to nesbuvir 0.01 µM for 24.0 h


TSS515557-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir 10.0 µM for 24.0 h


TSS515558-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir 3.33 µM for 24.0 h


TSS515559-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir 1.11 µM for 24.0 h


TSS515560-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir 0.37 µM for 24.0 h


TSS515561-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir 0.125 µM for 24.0 h


TSS515562-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir 0.04 µM for 24.0 h


TSS623725-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir 2.22 µM for 24.0 h


TSS623726-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir 0.74 µM for 24.0 h


TSS623727-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir 0.25 µM for 24.0 h


TSS623728-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir 0.08 µM for 24.0 h


TSS623729-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir 0.03 µM for 24.0 h


TSS623730-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to nesbuvir 0.01 µM for 24.0 h


TSS515829-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to nesbuvir 3.33 µM for 24.0 h


TSS515828-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to nesbuvir 10.0 µM for 24.0 h


TSS515830-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to nesbuvir 1.11 µM for 24.0 h


TSS515831-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to nesbuvir 0.37 µM for 24.0 h


TSS515832-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to nesbuvir 0.125 µM for 24.0 h


TSS515833-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to nesbuvir 0.04 µM for 24.0 h


TSS516145-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir 10.0 µM for 24.0 h


TSS516146-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir 3.33 µM for 24.0 h


TSS516147-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir 1.11 µM for 24.0 h


TSS516148-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir 0.37 µM for 24.0 h


TSS516149-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir 0.125 µM for 24.0 h


TSS516150-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir 0.04 µM for 24.0 h


TSS624059-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir 2.22 µM for 24.0 h


TSS624060-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir 0.74 µM for 24.0 h


TSS624061-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir 0.25 µM for 24.0 h


TSS624062-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir 0.08 µM for 24.0 h


TSS624063-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir 0.03 µM for 24.0 h


TSS624064-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to nesbuvir 0.01 µM for 24.0 h


TSS516462-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir 10.0 µM for 24.0 h


TSS516463-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir 3.33 µM for 24.0 h


TSS516464-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir 1.11 µM for 24.0 h


TSS516465-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir 0.37 µM for 24.0 h


TSS516466-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir 0.125 µM for 24.0 h


TSS516467-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir 0.04 µM for 24.0 h


TSS624395-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir 0.01 µM for 24.0 h


TSS624390-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir 2.22 µM for 24.0 h


TSS624391-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir 0.74 µM for 24.0 h


TSS624392-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir 0.25 µM for 24.0 h


TSS624393-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir 0.08 µM for 24.0 h


TSS624394-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to nesbuvir 0.03 µM for 24.0 h



TSP49122 - CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to nesbuvir Public

https://clue.io/data/CMap2020#LINCS2020

Experimental design

No experimental design provided

Results

No results provided